血清SIRT6、DR5、KL-6水平与重症肺炎并发ARDS患者病情及预后的关系OA
Study on the relationship between serum SIRT6,DR5,KL-6 levels and the condition and prognosis of patients with severe pneumonia complicated by ARDS
目的 探讨血清沉默调节蛋白6(SIRT6)、死亡受体5(DR5)、涎液化糖链抗原(KL-6)水平与重症肺炎并发急性呼吸窘迫综合征(ARDS)患者病情及预后的关系.方法 选取2022年5月至2024年5月在该院就诊的重症肺炎并发ARDS患者100例为ARDS组、重症肺炎患者100例为肺炎组,另选取同期在该院体检健康者100例为健康组.利用氧合指数评估重症肺炎并发ARDS患者严重程度,并将其分为轻度组、中度组、重度组.根据28 d随访结果,将重症肺炎并发ARDS患者分为生存组和死亡组.采用酶联免疫吸附试验检测各组血清SIRT6、DR5、KL-6水平,并分析其与重症肺炎并发 ARDS患者严重程度之间的相关性.采用Spearman相关分析重症肺炎并发ARDS患者血清SIRT6、DR5、KL-6水平与ARDS严重程度的相关性.采用多因素Logistic回归分析重症肺炎并发ARDS患者死亡的影响因素.绘制受试者工作特征(ROC)曲线评估血清SIRT6、DR5、KL-6对重症肺炎并发ARDS患者死亡的预测价值.结果 肺炎组、ARDS组血清SIRT6水平低于健康组,血清DR5、KL-6水平高于健康组,差异均有统计学意义(P<0.05);ARDS组血清SIRT6水平低于肺炎组,血清DR5、KL-6水平高于肺炎组,差异均有统计学意义(P<0.05).氧合指数评估结果显示,100例ARDS组患者中轻度组24例、中度组30例、重度组46例.中度组、重度组血清SIRT6水平低于轻度组,DR5、KL-6水平高于轻度组,差异均有统计学意义(P<0.05);重度组血清SIRT6水平低于中度组,DR5、KL-6水平高于中度组,差异均有统计学意义(P<0.05).Spearman相关分析结果显示,重症肺炎并发ARDS患者血清SIRT6水平与ARDS严重程度呈负相关(rs=—0.782,P<0.001),而血清DR5、KL-6水平与ARDS严重程度呈正相关(rs=0.653、0.610,均P<0.001).随访28 d结果显示,重症肺炎并发ARDS患者有63例纳入生存组,37例纳入死亡组.死亡组血清SIRT6水平低于生存组,血清DR5、KL-6水平高于生存组,差异均有统计学意义(P<0.05).多因素Logistic回归分析结果显示,血清SIRT6水平升高是重症肺炎并发ARDS患者死亡的保护因素(P<0.05),血清DR5、KL-6水平升高是重症肺炎并发ARDS患者死亡的危险因素(P<0.05).ROC曲线分析结果显示,血清SIRT6、DR5、KL-6联合预测重症肺炎并发 ARDS患者死亡的曲线下面积(AUC)大于各指标单独预测的AUC(P<0.05).结论 重症肺炎并发ARDS患者血清SIRT6水平较低,血清DR5、KL-6水平较高,且血清SIRT6、DR5、KL-6水平与ARDS病情加重和患者死亡风险增加有关,血清SIRT6、DR5、KL-6联合预测重症肺炎并发ARDS患者死亡的价值较高.
Objective To investigate the relationship between serum silent information regulator 6(SIRT6),death receptor 5(DR5),Krebs von den lungen-6(KL-6)levels and the condition and prognosis of patients with severe pneumonia complicated with acute respiratory distress syndrome(ARDS).Methods A total of 100 patients with severe pneumonia complicated by ARDS who were treated in the hospital were se-lected as the ARDS group,100 patients with severe pneumonia as the pneumonia group,and 100 healthy indi-viduals who underwent physical examinations in the hospital during the same period as the healthy group.The severity of patients with severe pneumonia complicated by ARDS was evaluated by the oxygenation index,and they were divided into the mild-degree group,the moderate-degree group and the severe-degree group.Based on the 28-day follow-up results,the patients with severe pneumonia complicated by ARDS were divided into the survival group and the death group.The serum levels of SIRT6,DR5 and KL-6 in each group were detec-ted by enzyme-linked immunosorbent assay.Spearman correlation analysis was used to analyze the correlation between the serum levels of SIRT6,DR5 and KL-6 and the severity of ARDS.Multivariate Logistic regression analysis was used to analyze the influencing factors for death in patients with severe pneumonia complicated by ARDS.The receiver operating characteristic(ROC)curve was plotted to evaluate the predictive value of serum SIRT6,DR5 and KL-6 for death in patients with severe pneumonia complicated by ARDS.Results The serum SIRT6 level in the pneumonia group and the ARDS group was lower than that in the healthy group,while the serum DR5 and KL-6 levels were higher than those in the healthy group,and the differences were all statistically significant(P<0.05).The serum SIRT6 level in the ARDS group was lower than that in the pneumonia group,and the serum DR5 and KL-6 levels were higher than those in the pneumonia group,with statistically significant differences(P<0.05).The results of oxygenation index evaluation showed that among the 100 patients in the ARDS group,there were 24 cases in the mild-degree group,30 cases in the moderate-de-gree group,and 46 cases in the severe-degree group.The serum SIRT6 levels in the moderate-degree group and severe-degree group were lower than that in the mild-degree group,and the DR5 and KL-6 levels were higher than those in the mild-degree group,with statistically significant differences(P<0.05).The serum SIRT6 level in the severe-degree group was lower than that in the moderate-degree group,and the DR5 and KL-6 lev-els were higher than those in the moderate-degree group,with statistically significant differences(P<0.05).The results of Spearman correlation analysis showed that the serum SIRT6 level in patients with severe pneu-monia complicated by ARDS was negatively correlated with the severity of ARDS(rs=-0.782,P<0.001),while the serum DR5 and KL-6 levels were positively correlated with the severity of ARDS(rs=0.653,0.610,both P<0.001).The 28-day follow-up results showed that 63 patients with severe pneumonia compli-cated by ARDS were included in the survival group,and 37 were included in the death group.The serum SIRT6 level in the death group was lower than that in the survival group,and the serum DR5 and KL-6 levels were higher than those in the survival group,with statistically significant differences(P<0.05).The results of multivariate Logistic regression analysis showed that increased serum SIRT6 level was a protective factor for death in patients with severe pneumonia complicated by ARDS(P<0.05),while increased serum DR5 and KL-6 levels were risk factors for death in patients with severe pneumonia complicated by ARDS(P<0.05).The results of ROC curve analysis showed that the area under the curve of the combined prediction of death in patients with severe pneumonia complicated by ARDS by serum SIRT6,DR5 and KL-6 was larger than that of each indicator alone(P<0.05).Conclusion In patients with severe pneumonia complicated by ARDS,the se-rum SIRT6 level is low,while the serum DR5 and KL-6 levels are high,and the serum levels of SIRT6,DR5 and KL-6 are related to the aggravation of ARDS and an increased risk of patient death.The combined predic-tion of death in patients with severe pneumonia complicated by ARDS by serum SIRT6,DR5 and KL-6 has a high value.
严政威;窦燕;王惠萍;姚奇;何宁;林凯玲;黄巍
第九〇九医院/厦门大学附属东南医院:重症医学科,福建 漳州 363000第九〇九医院/厦门大学附属东南医院:重症医学科,福建 漳州 363000第九〇九医院/厦门大学附属东南医院:血液内分泌科,福建 漳州 363000第九〇九医院/厦门大学附属东南医院:重症医学科,福建 漳州 363000第九〇九医院/厦门大学附属东南医院:重症医学科,福建 漳州 363000第九〇九医院/厦门大学附属东南医院:重症医学科,福建 漳州 363000第九〇九医院/厦门大学附属东南医院:重症医学科,福建 漳州 363000
医药卫生
重症肺炎急性呼吸窘迫综合征沉默调节蛋白6死亡受体5涎液化糖链抗原病情预后
severe pneumoniaacute respiratory distress syndromesilent information regulator 6death receptor 5krebs von den lungen-6disease conditionprognosis
《检验医学与临床》 2026 (2)
191-197,7
福建省自然科学基金项目(2023J011833).
评论